AUREUS ASSET MANAGEMENT, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
AUREUS ASSET MANAGEMENT, LLC portfolio value:
$513,000
portfolio value
AUREUS ASSET MANAGEMENT, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 139K | $200.16 | 2.56K | |
| Q2 2022 | share | 0.00% | 0 shares | -45K | $145.85 | 2.56K | |
| Q1 2022 | share | Increase | 0.00% | 2.56K shares | 419K | $163.29 | 2.56K |
| Q4 2016 | share | Decrease | -100.00% | -136.86K shares | -9.27M | $37.44 | 0 |
| Q3 2016 | share | Increase | +2.25% | 3.01K shares | 1.85M | $67.78 | 136.86K |
| Q2 2016 | share | Increase | +1.49% | 1.96K shares | -852K | $55.49 | 133.85K |
| Q1 2016 | share | Increase | +97.93% | 65.25K shares | 2.00M | $62.77 | 131.89K |